Neo Ivy Capital Management’s Amgen AMGN Stock Holding History

Neo Ivy Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-9,581	Closed	-$3.14M	–	331
2025 Q4	$3.14M	Buy	+9,581	New	+$3.04M	0.5%	87
2025 Q3	–	Sell	-2,337	Closed	-$653K	–	384
2025 Q2	$653K	Sell	2,337 -7,211	-76%	-$2.04M	0.21%	167
2025 Q1	$2.97M	Buy	9,548 +8,165	+590%	+$2.41M	0.95%	13
2024 Q4	$360K	Buy	+1,383	New	+$410K	0.07%	185
2023 Q3	–	Sell	-1,620	Closed	-$360K	–	321
2023 Q2	$360K	Buy	+1,620	New	+$376K	0.19%	157
2022 Q4	$878K	Buy	+3,342	New	+$896K	0.59%	39
2021 Q1	–	Sell	-256	Closed	-$59K	–	467
2020 Q4	$59K	Buy	+256	New	+$59K	0.07%	296

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Neo Ivy Capital Management's AMGN Position: Q1 2026 in Review

Neo Ivy Capital Management sold out of Amgen (AMGN) in Q1 2026, closing a stake of 9,581 shares — an estimated $3.14M sold.

Neo Ivy Capital Management first reported a position in AMGN in Q4 2020 and held it in 7 quarters. The position peaked at $3.14M in Q4 2025. 3,132 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Neo Ivy Capital Management reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
Neo Ivy Capital Management sold 9,581 Amgen shares in Q1 2026, an estimated $3.14M.
Neo Ivy Capital Management first reported a position in Amgen in Q4 2020 and held it in 7 quarters.
Neo Ivy Capital Management's Amgen position peaked at $3.14M in Q4 2025.
3,132 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Neo Ivy Capital Management's 13F filing for Q1 2026, filed 15 May 2026.